|
Q |
Colcr1 |
Colorectal carcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 4:1...29,494,328
|
|
Q |
Colcr2 |
Colorectal carcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:2,266,368...22,711,984
|
|
Q |
Colcr3 |
Colorectal carcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:2,249,477...22,066,430
|
|
Q |
Colcr4 |
Colorectal carcinoma resistance QTL4 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:20,338,777...62,613,667
|
|
Q |
Colcr5 |
Colorectal carcinoma resistance QTL 5 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:122,549,046...137,801,795
|
|
Q |
Colcr6 |
Colorectal carcinoma resistance QTL 6 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:73,690,518...99,794,247
|
|
Q |
Colcr7 |
Colorectal carcinoma resistance QTL 7 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr17:2,115,149...21,881,669
|
|
Q |
Colcr8 |
Colorectal carcinoma resistance QTL 8 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:22,066,242...52,293,055
|
|
Q |
Colcr9 |
Colorectal carcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr20:1,530,655...46,530,655
|
|
Q |
Colcs1 |
Colorectal carcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 5:121,846,814...166,846,814
|
|
|
Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr10:6,154,182...15,990,232
|
|
Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 8:40,713,066...82,925,667
|
|
Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 6:82,523,650...110,548,006
|
|
Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 3:29,463,235...118,376,539
|
|
Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 4:1...32,584,199
|
|
Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr18:51,464,733...83,218,561
|
|
Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 4:78,878,504...123,878,504
|
|
Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 8:54,237,644...99,103,503
|
|
Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 4:109,866,907...167,139,601
|
|
Q |
Hcas1 |
Hepatocarcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 7:91,412,594...129,807,172
|
|
Q |
Hcas2 |
Hepatocarcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 1:5,925,874...115,540,829
|
|
Q |
Hcas3 |
Hepatocarcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 1:144,267,353...222,987,745
|
|
Q |
Hcas4 |
Hepatocarcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr16:4,227,609...46,975,965
|
|
Q |
Hcas5 |
Hepatocarcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 1:176,426,412...257,976,495
|
|
Q |
Hcas6 |
Hepatocarcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr14:39,057,237...83,368,335
|
|
Q |
Hcas7 |
Hepatocarcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr15:2,266,368...46,921,453
|
|
Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 7:34,293,282...79,293,282
|
|
Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 1:233,948,574...260,522,016
|
|
Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 2:1...41,244,106
|
|
Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:1...42,356,786
|
|
Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:59,874,408...85,581,182
|
|
Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:74,862,117...85,581,182
|
|
|
Q |
Hcar15 |
Hepatocarcinoma resistance QTL 15 |
|
IDA |
|
RGD |
PMID:15771619 |
RGD:1358145 |
NCBI chr 1:153,136,852...260,522,016
|
|
|
Q |
Tcas10 |
Tongue tumor susceptibility QTL 10 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr10:31,297,439...76,297,439
|
|
Q |
Tcas11 |
Tongue tumor susceptibility QTL 11 |
|
IDA |
|
RGD |
PMID:16527513 |
RGD:1578522 |
NCBI chr 5:46,711,509...161,317,411
|
|
Q |
Tcas2 |
Tongue tumor susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:192,485,903...199,050,587
|
|
Q |
Tcas3 |
Tongue tumor susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 4:10,814,170...91,360,527
|
|
Q |
Tcas4 |
Tongue tumor susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr14:17,622,561...42,337,007
|
|
Q |
Tcas5 |
Tongue tumor susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr19:9,977,753...39,654,489
|
|
Q |
Tcas6 |
Tongue tumor susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:92,948,896...144,267,916
|
|
Q |
Tcas7 |
Tongue tumor susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15876484 |
RGD:1358147 |
NCBI chr19:24,817,978...39,654,489
|
|
Q |
Tcas8 |
Tongue tumor susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
|
|
Q |
Tcas9 |
Tongue tumor susceptibility QTL 9 |
|
IDA |
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 6:1...37,618,905
|
|
|
Q |
Mamtr1 |
Mammary tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:12844486 |
RGD:631852 |
NCBI chr 5:12,789,751...113,558,310
|
|
Q |
Mamtr2 |
Mammary tumor resistance QTL 2 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:7,887,772...12,654,247
|
|
Q |
Mamtr3 |
Mammary tumor resistance QTL 3 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:32,373,770...43,665,178
|
|
Q |
Mamtr4 |
Mammary tumor resistance QTL 4 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:16,491,740...61,491,740
|
|
Q |
Mamtr5 |
Mammary tumor resistance QTL 5 |
|
IDA |
65mg/kg body mass |
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr 5:18,873,947...63,873,947
|
|
Q |
Mamtr6 |
Mammary tumor resistance QTL 6 |
|
IDA |
65mg/kg body mass |
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr18:19,278,901...83,218,561
|
|
Q |
Mamtr7 |
Mammary tumor resistance QTL 7 |
|
IDA |
65mg/kg body mass |
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr10:9,658,275...104,670,812
|
|
Q |
Mamtr8 |
Mammary tumor resistance QTL 8 |
|
IDA |
65mg/ml body mass |
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr18:31,359,408...83,218,561
|
|
Q |
Mcs1 |
Mammary carcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:8168109 |
RGD:61080 |
NCBI chr 2:7,887,772...23,319,447
|
|
Q |
Mcs12 |
Mammary carcinoma susceptibility QTL 12 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:58,973,449...60,051,321
|
|
Q |
Mcs13 |
Mammary carcinoma susceptibility QTL 13 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:63,190,890...69,927,503
|
|
Q |
Mcs14 |
Mammary carcinoma susceptibility QTL 14 |
|
IDA |
|
RGD |
PMID:16266982 |
RGD:1559294 |
NCBI chr 5:76,369,776...80,813,390
|
|
Q |
Mcs15 |
Mammary carcinoma susceptibility QTL 15 |
|
IDA |
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr10:85,565,469...103,884,409
|
|
Q |
Mcs16 |
Mammary carcinoma susceptibility QTL 16 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:2,244,390...43,433,040
|
|
Q |
Mcs17 |
Mammary carcinoma susceptibility QTL 17 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:197,670,404...242,670,404
|
|
Q |
Mcs18 |
Mammary carcinoma susceptibility QTL 18 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 2:7,887,772...42,804,738
|
|
Q |
Mcs19 |
Mammary carcinoma susceptibility QTL 19 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 5:99,485,997...103,690,167
|
|
Q |
Mcs2 |
Mammary carcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 7:19,032,807...35,526,300
|
|
Q |
Mcs20 |
Mammary carcinoma susceptibility QTL 20 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 9:13,533,770...42,791,750
|
|
Q |
Mcs21 |
Mammary carcinoma susceptibility QTL 21 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr10:28,875,650...52,200,160
|
|
Q |
Mcs22 |
Mammary carcinoma susceptibility QTL 22 |
|
IDA |
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr18:52,539,763...63,933,058
|
|
Q |
Mcs23 |
Mammary carcinoma susceptibility QTL 23 |
|
IDA |
|
RGD |
PMID:17404222 |
RGD:1601189 |
|
|
Q |
Mcs24 |
Mammary carcinoma susceptibility QTL 24 |
|
IDA |
|
RGD |
PMID:17404222 |
RGD:1601189 |
NCBI chr 5:64,719,390...109,719,390
|
|
Q |
Mcs25 |
Mammary carcinoma susceptibility QTL 25 |
|
IDA |
65mg/kg body weight |
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:10,894,415...110,548,006
|
|
Q |
Mcs26 |
Mammary carcinoma susceptibility QTL 26 |
|
IDA |
65mg/kg body weight |
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:106,752,656...132,339,866
|
|
Q |
Mcs27 |
Mammary carcinoma susceptibility QTL 27 |
|
IDA |
65mg/kg body weight |
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr13:43,437,904...47,841,255
|
|
Q |
Mcs28 |
Mammary carcinoma susceptibility QTL 28 |
|
IDA |
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:77,743,239...78,039,084
|
|
Q |
Mcs29 |
Mammary carcinoma susceptibility QTL 29 |
|
IDA |
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:77,816,155...77,988,860
|
|
Q |
Mcs3 |
Mammary carcinoma susceptibility QTL 3 |
|
IDA |
65mg/kg body weight |
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 1:102,268,556...147,268,556
|
|
Q |
Mcs4 |
Mammary carcinoma susceptibility QTL 4 |
|
IDA |
65mg/kg body weight |
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 8:16,290,444...61,290,444
|
|
Q |
Mcs5 |
Mammary carcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 5:55,805,606...132,207,589
|
|
Q |
Mcs6 |
Mammary carcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 7:26,737,401...63,902,784
|
|
Q |
Mcs7 |
Mammary carcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr10:72,224,939...107,211,142
|
|
Q |
Mcs8 |
Mammary carcinoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr14:3,813,074...24,531,477
|
|
Q |
Mcsm1 |
Mammary carcinoma susceptibility modifier QTL 1 |
|
IDA |
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 6:58,632,962...103,632,962
|
|
|
Q |
Iresp1 |
Immunoglobin response QTL1 |
|
IDA |
|
RGD |
PMID:10898507 |
RGD:619646 |
NCBI chr20:9,039,719...13,461,775
|
|
Q |
Iresp2 |
Immunoglobin response QTL2 |
|
IDA |
|
RGD |
PMID:10898507 |
RGD:619646 |
NCBI chr10:22,918,268...36,400,810
|
|
Q |
Iresp3 |
Immunoglobin response QTL3 |
|
IDA |
|
RGD |
PMID:10898507 |
RGD:619646 |
NCBI chr 9:2,745,799...5,857,951
|
|
|
Q |
Glom27 |
Glomerulus QTL 27 |
|
IDA |
|
RGD |
PMID:22445570 |
RGD:7207870 |
NCBI chr13:20,605,871...101,339,738
|
|
|
Q |
Hcar4 |
Hepatocarcinoma resistance QTL 4 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 1:193,422,268...214,537,671
|
|
Q |
Hcar5 |
Hepatocarcinoma resistance QTL 5 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 1:214,537,555...226,660,468
|
|
Q |
Hcar6 |
Hepatocarcinoma resistance QTL 6 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
|
|
Q |
Hcar7 |
Hepatocarcinoma resistance QTL 7 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:70,808,386...115,808,386
|
|
Q |
Hcar8 |
Hepatocarcinoma resistance QTL 8 |
|
IDA |
|
RGD |
PMID:10850431 |
RGD:619609 |
NCBI chr 4:123,143,783...168,143,783
|
|
|
Q |
Tcas1 |
Tongue tumor susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr19:2,316,121...47,316,121
|
|
Q |
Tcat1 |
Tongue tumor resistance QTL 1 |
|
IDA |
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr 1:99,267,916...144,267,916
|
|
|
Q |
Gcr1 |
Gastric cancer resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 4:120,260,281...147,278,687
|
|
Q |
Gcr2 |
Gastric cancer resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 3:8,658,162...27,494,778
|
|
Q |
Gcr3 |
Gastric cancer resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr16:17,696,791...82,635,055
|
|
Q |
Gcs1 |
Gastric cancer susceptibility QTL1 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr15:76,306,099...101,769,107
|
|
|
Q |
Tls1 |
T-lymphoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 5:90,450,144...135,450,144
|
|
Q |
Tls2 |
T-lymphoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 7:80,221,299...109,401,111
|
|
Q |
Tls3 |
T-lymphoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr10:51,774,612...95,600,334
|
|
|
Q |
Bw143 |
Body weight QTL 143 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:34,430,484...82,490,359
|
|
Q |
Bw144 |
Body weight QTL 144 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:22,710,685...34,430,484
|
|
Q |
Bw145 |
Body weight QTL 145 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr10:41,944,526...78,307,017
|
|
Q |
Vie1 |
Viral induced encephalitis QTL 1 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:34,430,484...82,490,359
|
|
Q |
Vie2 |
Viral induced encephalitis QTL 2 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 3:145,956,084...169,034,231
|
|
Q |
Vie3 |
Viral induced encephalitis QTL 3 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 6:96,833,997...140,994,061
|
|
Q |
Vie4 |
Viral induced encephalitis QTL 4 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:62,933,508...82,490,359
|
|
Q |
Vie5 |
Viral induced encephalitis QTL 5 |
|
IDA |
|
RGD |
PMID:22761571 |
RGD:7240516 |
NCBI chr 4:34,430,484...82,490,359
|
|
|
Q |
Iddm20 |
Insulin dependent diabetes mellitus QTL 20 |
|
IDA |
|
RGD |
PMID:15793267 |
RGD:1358924 |
NCBI chr17:13,986,773...21,975,515
|
|
Q |
Iddm37 |
Insulin dependent diabetes mellitus QTL 37 |
|
IDA |
|
RGD |
PMID:19720792 |
RGD:2313174 |
NCBI chr20:1,527,842...46,527,842
|
|
|
Q |
Mcs30 |
Mammary carcinoma susceptibility QTL 30 |
|
IDA |
|
RGD |
PMID:24023717 |
RGD:7327193 |
NCBI chr12:797,729...8,525,593
|
|
|
Q |
Hcar1 |
Hepatocarcinoma resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr10:6,154,182...15,990,232
|
|
Q |
Hcar10 |
Hepatocarcinoma resistance QTL 10 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 8:40,713,066...82,925,667
|
|
Q |
Hcar11 |
Hepatocarcinoma resistance QTL 11 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 6:82,523,650...110,548,006
|
|
Q |
Hcar12 |
Hepatocarcinoma resistance QTL 12 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 3:29,463,235...118,376,539
|
|
Q |
Hcar13 |
Hepatocarcinoma resistance QTL 13 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 4:1...32,584,199
|
|
Q |
Hcar14 |
Hepatocarcinoma resistance QTL 14 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr18:51,464,733...83,218,561
|
|
Q |
Hcar2 |
Hepatocarcinoma resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 4:78,878,504...123,878,504
|
|
Q |
Hcar3 |
Hepatocarcinoma resistance QTL 3 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 8:54,237,644...99,103,503
|
|
Q |
Hcar9 |
Hepatocarcinoma resistance QTL 9 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 4:109,866,907...167,139,601
|
|
Q |
Hcas1 |
Hepatocarcinoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 7:91,412,594...129,807,172
|
|
Q |
Hcas2 |
Hepatocarcinoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10493520 |
RGD:619598 |
NCBI chr 1:5,925,874...115,540,829
|
|
Q |
Hcas3 |
Hepatocarcinoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr 1:144,267,353...222,987,745
|
|
Q |
Hcas4 |
Hepatocarcinoma susceptibility QTL 4 |
|
IDA |
|
RGD |
PMID:12154055 |
RGD:629566 |
NCBI chr16:4,227,609...46,975,965
|
|
Q |
Hcas5 |
Hepatocarcinoma susceptibility QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 1:176,426,412...257,976,495
|
|
Q |
Hcas6 |
Hepatocarcinoma susceptibility QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr14:39,057,237...83,368,335
|
|
Q |
Hcas7 |
Hepatocarcinoma susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr15:2,266,368...46,921,453
|
|
Q |
Hcas8 |
Hepatocarcinoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:17079458 |
RGD:1599590 |
NCBI chr16:1...22,477,621
|
|
Q |
Lnnr1 |
Liver neoplastic nodule remodeling QTL 1 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 7:34,293,282...79,293,282
|
|
Q |
Lnnr2 |
Liver neoplastic nodule remodeling QTL 2 |
|
IDA |
|
RGD |
PMID:12672032 |
RGD:629574 |
NCBI chr 1:233,948,574...260,522,016
|
|
Q |
Lnnr3 |
Liver neoplastic nodule remodeling QTL 3 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr 2:1...41,244,106
|
|
Q |
Lnnr4 |
Liver neoplastic nodule remodeling QTL 4 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:1...42,356,786
|
|
Q |
Lnnr5 |
Liver neoplastic nodule remodeling QTL 5 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:59,874,408...85,581,182
|
|
Q |
Lnnr6 |
Liver neoplastic nodule remodeling QTL 6 |
|
IDA |
|
RGD |
PMID:15185337 |
RGD:737884 |
NCBI chr13:74,862,117...85,581,182
|
|
|
Q |
Aia10 |
Adjuvant induced arthritis QTL 10 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr15:75,788,062...101,769,107
|
|
Q |
Aia11 |
Adjuvant induced arthritis QTL 11 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:60,781,426...86,533,673
|
|
Q |
Aia12 |
Adjuvant induced arthritis QTL 12 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:38,281,509...83,281,509
|
|
Q |
Aia13 |
Adjuvant induced arthritis QTL 13 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 2:76,539,322...77,991,361
|
|
Q |
Aia14 |
Adjuvant induced arthritis QTL 14 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
|
|
Q |
Aia15 |
Adjuvant induced arthritis QTL 15 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:17,004,598...62,004,598
|
|
Q |
Aia16 |
Adjuvant induced arthritis QTL 16 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:59,238,038...104,238,038
|
|
Q |
Aia17 |
Adjuvant induced arthritis QTL 17 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:81,737,938...126,737,938
|
|
Q |
Aia18 |
Adjuvant induced arthritis QTL 18 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:8,736,635...53,736,635
|
|
Q |
Aia19 |
Adjuvant induced arthritis QTL 19 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:66,978,955...107,211,142
|
|
Q |
Aia20 |
Adjuvant induced arthritis QTL 20 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:37,565,079...82,565,079
|
|
Q |
Aia21 |
Adjuvant induced arthritis QTL 21 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:9,831,541...54,831,541
|
|
Q |
Aia22 |
Adjuvant induced arthritis QTL 22 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:1...34,266,636
|
|
Q |
Aia23 |
Adjuvant induced arthritis QTL 23 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:11,766,535...32,331,607
|
|
Q |
Aia24 |
Adjuvant induced arthritis QTL 24 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr15:52,847,908...73,690,657
|
|
Q |
Aia25 |
Adjuvant induced arthritis QTL 25 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:50,909,196...60,781,426
|
|
Q |
Aia26 |
Adjuvant induced arthritis QTL 26 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:38,281,509...83,281,509
|
|
Q |
Aia27 |
Adjuvant induced arthritis QTL 27 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr20:2,892,597...26,381,954
|
|
Q |
Aia6 |
Adjuvant induced arthritis QTL 6 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:66,978,955...107,211,142
|
|
Q |
Aia7 |
Adjuvant induced arthritis QTL 7 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr10:37,565,079...82,565,079
|
|
Q |
Aia8 |
Adjuvant induced arthritis QTL 8 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:9,831,541...54,831,541
|
|
Q |
Aia9 |
Adjuvant induced arthritis QTL 9 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr13:11,766,535...32,331,607
|
|
Q |
Ginf1 |
Gastrointestinal inflammation QTL 1 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:4,705,810...49,705,810
|
|
Q |
Ginf2 |
Gastrointestinal inflammation QTL 2 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:4,705,810...49,705,810
|
|
Q |
Ginf3 |
Gastrointestinal inflammation QTL 3 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:49,920,154...86,533,673
|
|
Q |
Livw3 |
Liver weight QTL 3 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:4,705,810...49,705,810
|
|
Q |
Wbc3 |
White blood cell count QTL 3 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 5:105,999,803...150,999,803
|
|
Q |
Wbc4 |
White blood cell count QTL 4 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 7:1...35,342,956
|
|
Q |
Wbc5 |
White blood cell count QTL 5 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:8,736,635...53,736,635
|
|
|
Q |
Apr1 |
Acute phase response QTL 1 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr12:19,144,362...46,669,029
|
|
Q |
Apr2 |
Acute phase response QTL 2 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr 5:135,927,956...166,875,058
|
|
Q |
Apr3 |
Acute phase response QTL 3 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr10:15,275,955...60,275,955
|
|
Q |
Apr4 |
Acute phase response QTL 4 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr12:1,172,005...46,172,005
|
|
Q |
Apr5 |
Acute phase response QTL 5 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr12:1...44,503,507
|
|
Q |
Apr6 |
Acute phase response QTL 6 |
|
IDA |
|
RGD |
PMID:11817600 |
RGD:629561 |
NCBI chr14:1...41,131,407
|
|
Q |
Oia7 |
Oil induced arthritis QTL 7 |
|
IDA |
|
RGD |
PMID:12915467 |
RGD:730281 |
NCBI chr 4:156,050,654...157,232,313
|
|
Q |
Pia1 |
Pristane induced arthritis QTL 1 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
|
|
Q |
Pia10 |
Pristane induced arthritis QTL 10 |
|
IDA |
|
RGD |
PMID:12209529 |
RGD:629569 |
NCBI chr10:23,444,813...104,060,283
|
|
Q |
Pia11 |
Pristane induced arthritis QTL 11 |
|
IDA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr 1:136,830,018...181,830,018
|
|
Q |
Pia12 |
Pristane induced arthritis QTL 12 |
|
IDA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr12:20,259,417...23,672,083
|
|
Q |
Pia13 |
Pristane induced arthritis QTL 13 |
|
IDA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr14:40,793,460...98,037,301
|
|
Q |
Pia14 |
Pristane induced arthritis QTL 14 |
|
IDA |
|
RGD |
PMID:12111642 |
RGD:631225 |
NCBI chr16:55,711,087...83,402,471
|
|
Q |
Pia15 |
Pristane induced arthritis QTL 15 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr10:1...24,158,324
|
|
Q |
Pia16 |
Pristane induced arthritis QTL 16 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr 6:45,790,088...104,200,226
|
|
Q |
Pia17 |
Pristane induced arthritis QTL 17 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr 7:73,829,340...130,221,005
|
|
Q |
Pia18 |
Pristane induced arthritis QTL 18 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr 8:75,311,938...82,925,521
|
|
Q |
Pia19 |
Pristane induced arthritis QTL 19 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr18:73,997,140...79,532,029
|
|
Q |
Pia2 |
Pristane induced arthritis QTL 2 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr 4:21,333,343...62,278,020
|
|
Q |
Pia20 |
Pristane induced arthritis QTL 20 |
|
IDA |
|
RGD |
PMID:14624754 |
RGD:730280 |
NCBI chr14:9,088,978...39,057,237
|
|
Q |
Pia21 |
Pristane induced arthritis QTL 21 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr20:3,621,656...4,606,812
|
|
Q |
Pia22 |
Pristane induced arthritis QTL 22 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr12:1...44,465,750
|
|
Q |
Pia23 |
Pristane induced arthritis QTL 23 |
|
IDA |
|
RGD |
PMID:12817024 |
RGD:631850 |
NCBI chr 4:131,730,738...167,139,601
|
|
Q |
Pia24 |
Pristane induced arthritis QTL 24 |
|
IDA |
|
RGD |
PMID:14611807 |
RGD:728382 |
NCBI chr 6:112,636,280...140,994,061
|
|
Q |
Pia25 |
Pristane induced arthritis QTL 25 |
|
IDA |
|
RGD |
PMID:15944295 |
RGD:1359065 |
NCBI chr10:96,120,911...104,060,283
|
|
Q |
Pia26 |
Pristane induced arthritis QTL 26 |
|
IDA |
|
RGD |
PMID:15944295 |
RGD:1359065 |
NCBI chr10:31,224,026...75,632,053
|
|
Q |
Pia27 |
Pristane induced arthritis QTL 27 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr11:82,566,545...83,440,803
|
|
Q |
Pia28 |
Pristane induced arthritis QTL 28 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 4:73,630,210...118,630,210
|
|
Q |
Pia29 |
Pristane induced arthritis QTL 29 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr16:21,735,975...66,735,975
|
|
Q |
Pia3 |
Pristane induced arthritis QTL 3 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr 6:94,968,928...137,848,904
|
|
Q |
Pia30 |
Pristane induced arthritis QTL 30 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 3:27,936,919...72,936,919
|
|
Q |
Pia31 |
Pristane induced arthritis QTL 31 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 1:10,992,065...55,992,065
|
|
Q |
Pia32 |
Pristane induced arthritis QTL 32 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 4:105,789,505...150,789,505
|
|
Q |
Pia33 |
Pristane induced arthritis QTL 33 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia34 |
Pristane induced arthritis QTL 34 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
|
|
Q |
Pia35 |
Pristane induced arthritis QTL 35 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 1:216,255,568...260,522,016
|
|
Q |
Pia36 |
Pristane induced arthritis QTL 36 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr 1:43,333,002...88,333,002
|
|
Q |
Pia37 |
Pristane induced arthritis QTL 37 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr12:13,198,157...46,669,029
|
|
Q |
Pia38 |
Pristane induced arthritis QTL 38 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr12:1...44,503,507
|
|
Q |
Pia39 |
Pristane induced arthritis QTL 39 |
|
IDA |
|
RGD |
PMID:14674011 |
RGD:2302026 |
NCBI chr14:8,267,090...53,267,090
|
|
Q |
Pia4 |
Pristane induced arthritis QTL 4 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr12:13,635,523...30,827,399
|
|
Q |
Pia40 |
Pristane induced arthritis QTL 40 |
|
IDA |
|
RGD |
PMID:19180494 |
RGD:2306838 |
NCBI chr20:1,527,959...5,304,575
|
|
Q |
Pia41 |
Pristane induced arthritis QTL 41 |
|
IDA |
|
RGD |
PMID:20072140 |
RGD:6892695 |
NCBI chr 1:178,810,256...180,814,005
|
|
Q |
Pia42 |
Pristane induced arthritis QTL 42 |
|
IDA |
|
RGD |
PMID:17329308 |
RGD:1600250 |
NCBI chr12:19,610,870...42,828,880
|
|
Q |
Pia5 |
Pristane induced arthritis QTL 5 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr 4:62,277,855...128,289,560
|
|
Q |
Pia6 |
Pristane induced arthritis QTL 6 |
|
IDA |
|
RGD |
PMID:9843218 |
RGD:61089 |
NCBI chr14:18,631,345...42,337,007
|
|
Q |
Pia7 |
Pristane induced arthritis QTL 7 |
|
IDA |
|
RGD |
PMID:11090241 |
RGD:629570 |
NCBI chr 4:131,730,738...167,139,601
|
|
Q |
Pia8 |
Pristane induced arthritis QTL 8 |
|
IDA |
|
RGD |
PMID:11090241 |
RGD:629570 |
NCBI chr 1:1...65,833,076
|
|
Q |
Pia9 |
Pristane induced arthritis QTL 9 |
|
IDA |
|
RGD |
PMID:12571866 |
RGD:629560 |
NCBI chr 4:80,694,870...125,694,870
|
|
|
Q |
Scwia1 |
Streptococcal cell wall induced arthritis QTL 1 |
|
IDA |
|
RGD |
PMID:10331011 |
RGD:61064 |
NCBI chr 4:106,805,662...151,805,662
|
|
|
Q |
Toxo1 |
Toxoplasma gondii resistance QTL 1 |
|
IDA |
|
RGD |
PMID:16407112 |
RGD:1578521 |
NCBI chr10:52,200,030...59,378,278
|
|
|
Q |
Tspe1 |
Trichinella spiralis expulsion QTL 1 |
|
IDA |
|
RGD |
PMID:16465509 |
RGD:1578305 |
NCBI chr 9:61,381,434...65,691,299
|
|
|
Q |
Cia1 |
Collagen induced arthritis QTL 1 |
|
IDA |
|
RGD |
PMID:8782824 |
RGD:61062 |
NCBI chr20:3,621,656...14,101,050
|
|
Q |
Cia10 |
Collagen induced arthritis QTL 10 |
|
IDA |
|
RGD |
PMID:9870869 |
RGD:61063 |
NCBI chr 2:179,946,951...224,946,951
|
|
Q |
Cia11 |
Collagen induced arthritis QTL 11 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr 3:30,356,773...98,535,386
|
|
Q |
Cia12 |
Collagen induced arthritis QTL 12 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr12:13,635,523...35,682,913
|
|
Q |
Cia13 |
Collagen induced arthritis QTL 13 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 4:132,642,577...167,139,601
|
|
Q |
Cia14 |
Collagen induced arthritis QTL 14 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr19:10,827,970...43,544,039
|
|
Q |
Cia15 |
Collagen induced arthritis QTL 15 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 9:5,109,826...42,921,101
|
|
Q |
Cia16 |
Collagen induced arthritis QTL 16 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr10:6,357,896...96,121,100
|
|
Q |
Cia17 |
Collagen induced arthritis QTL 17 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr18:31,359,408...70,263,868
|
|
Q |
Cia18 |
Collagen induced arthritis QTL 18 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr X:14,843,113...120,568,734
|
|
Q |
Cia19 |
Collagen induced arthritis QTL 19 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr X:65,612,192...120,568,734
|
|
Q |
Cia2 |
Collagen induced arthritis QTL 2 |
|
IDA |
|
RGD |
PMID:8782824 |
RGD:61062 |
NCBI chr 1:78,430,754...91,209,302
|
|
Q |
Cia20 |
Collagen induced arthritis QTL 20 |
|
IDA |
|
RGD |
PMID:11003387 |
RGD:631168 |
NCBI chr10:23,444,813...104,060,283
|
|
Q |
Cia21 |
Collagen induced arthritis QTL 21 |
|
IDA |
|
RGD |
PMID:11003387 |
RGD:631168 |
NCBI chr10:14,487,011...104,060,283
|
|
Q |
Cia22 |
Collagen induced arthritis QTL 22 |
|
IDA |
|
RGD |
PMID:11003387 |
RGD:631168 |
NCBI chr10:40,035,094...104,060,283
|
|
Q |
Cia23 |
Collagen induced arthritis QTL 23 |
|
IDA |
|
RGD |
PMID:11003387 |
RGD:631168 |
NCBI chr10:40,035,094...104,060,283
|
|
Q |
Cia24 |
Collagen induced arthritis QTL 24 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr 4:146,565,735...175,236,377
|
|
Q |
Cia25 |
Collagen induced arthritis QTL 25 |
|
IDA |
|
RGD |
PMID:15334486 |
RGD:1285224 |
NCBI chr12:19,610,889...35,682,913
|
|
Q |
Cia26 |
Collagen induced arthritis QTL 26 |
|
IDA |
|
RGD |
PMID:15334486 |
RGD:1285224 |
NCBI chr18:54,709,769...83,828,827
|
|
Q |
Cia27 |
Collagen induced arthritis QTL 27 |
|
IDA |
|
RGD |
PMID:9870869 |
RGD:61063 |
NCBI chr10:76,452,683...107,211,142
|
|
Q |
Cia28 |
Collagen induced arthritis QTL 28 |
|
IDA |
|
RGD |
PMID:15944295 |
RGD:1359065 |
NCBI chr10:96,120,911...104,060,283
|
|
Q |
Cia29 |
Collagen induced arthritis QTL 29 |
|
IDA |
|
RGD |
PMID:15944295 |
RGD:1359065 |
NCBI chr10:33,973,921...78,973,921
|
|
Q |
Cia3 |
Collagen induced arthritis QTL 3 |
|
IDA |
|
RGD |
PMID:8782824 |
RGD:61062 |
NCBI chr 4:103,194,656...148,194,656
|
|
Q |
Cia4 |
Collagen induced arthritis QTL 4 |
|
IDA |
|
RGD |
PMID:8782824 |
RGD:61062 |
NCBI chr 7:58,113,224...62,004,598
|
|
Q |
Cia5 |
Collagen induced arthritis QTL 5 |
|
IDA |
|
RGD |
PMID:8782824 |
RGD:61062 |
NCBI chr10:91,228,102...104,060,283
|
|
Q |
Cia6 |
Collagen induced arthritis QTL 6 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 8:82,460,758...122,812,818
|
|
Q |
Cia7 |
Collagen induced arthritis QTL 7 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 2:59,324,377...141,596,857
|
|
Q |
Cia8 |
Collagen induced arthritis QTL 8 |
|
IDA |
|
RGD |
PMID:10398805 |
RGD:61069 |
|
|
Q |
Cia9 |
Collagen induced arthritis QTL 9 |
|
IDA |
|
RGD |
PMID:9870869 |
RGD:61063 |
|
|
Q |
Ciaa1 |
CIA Autoantibody QTL 1 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr20:2,646,395...4,597,031
|
|
Q |
Ciaa2 |
CIA Autoantibody QTL 2 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr10:63,221,094...107,211,142
|
|
Q |
Ciaa3 |
CIA Autoantibody QTL 3 |
|
IDA |
|
RGD |
PMID:10857786 |
RGD:61066 |
NCBI chr 9:7,954,720...22,071,169
|
|
Q |
Ciaa4 |
CIA Autoantibody QTL 4 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 4:126,395,976...167,139,601
|
|
Q |
Ciaa5 |
CIA Autoantibody QTL 5 |
|
IDA |
|
RGD |
PMID:11001927 |
RGD:61067 |
NCBI chr 5:94,858,972...143,070,159
|
|